NEWS
View news from our Featured Companies.
Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)
This award recognizes Dr. Nkrumah-Elie's dedication to advancing scientific excellence for ChromaDex's leading external research program and mentorship in the dietary supplement industry LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide...
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseasesSARASOTA, Fla. and MIAMI, Oct. 14, 2024 -- INVO Bioscience ("INVO") (NASDAQ: INVO) today announced it has closed its merger with NAYA...
ARIANNE PHOSPHATE RECEIVES STRATEGIC INVESTMENT FROM A GLOBAL MINING COMPANY
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Oct. 10, 2024 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
PORTLAND, Maine, Oct. 08, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Jewett-Cameron Changes NASDAQ Trading Symbol
NORTH PLAINS, Ore., Oct. 08, 2024 -- Jewett-Cameron Trading Company Ltd. ("Jewett-Cameron") (Nasdaq: JCTCF), a company committed to innovative products that enrich outdoor spaces, is changing its NASDAQ trading symbol for its common shares. The trading symbol is...
New York City to Pursue Rat Contraception Pilot Program
PHOENIX, Oct. 8, 2024 -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces that the New York City Council has approved a bill to implement a rat contraception pilot program. From the bill, the term "rat...
Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit
CUPERTINO, Calif., Oct. 08, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Greenfire Resources Announces Future Growth Plans, Including Projects Under Development to Increase Net Facility Production Capacity by 74%, Representing Significant Potential Value for Shareholders
Calgary, Alberta--(October 7, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta, Canada, is...
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
WINTER SPRINGS, Fla., Oct. 03, 2024 -- IRADIMED CORPORATION ("Iradimed") (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that it will participate in the 3rd Annual ROTH Healthcare...
Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
CUPERTINO, Calif., Oct. 02, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Jewett-Cameron Partners with Continental Sales & Marketing, Inc. to Expand Distribution in Home Improvement Retailers
NORTH PLAINS, Ore., Oct. 01, 2024 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF), a company committed to innovative products that enrich outdoor spaces, today announced it has partnered with Continental Sales & Marketing, Inc. ("CSM") to expand...
Precision Optics Corporation to Participate in Lytham Partners Fall 2024 Investor Conference Today
GARDNER, Mass., Oct. 01, 2024 -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced today it will participate in a webcast...
Greenfire Announces Date for Rights Plan Hearing with the Alberta Securities Commission and Resignation of Two Directors
Calgary, Alberta--(September 30, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta, Canada...
PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX for the Prevention of Abdominal Colorectal Surgical Site Infections
Unblinded Interim Analysis to be Conducted During the Current Quarter Top-line Results Anticipated in First Quarter of 2025 PETACH TIKVA, Israel, Oct. 01, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to...
Precision Optics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Conference Call Scheduled for today, September 30, 2024, at 5:00pm ET.GARDNER, Mass., Sept. 30, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace...
Jewett-Cameron to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
NORTH PLAINS, Ore., Sept. 30, 2024 -- Jewett-Cameron Trading Company Ltd. ("Jewett-Cameron") (Nasdaq: JCTCF), a company committed to innovative products that enrich outdoor spaces, announced today it will participate in a webcasted presentation and host one-on-one...
LiqTech International, Inc. Announces Private Placement Transaction of up to $10 Million With Existing Institutional Investors
BALLERUP, Denmark, Sept. 30, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration technology company that manufactures and markets highly specialized filtration products and systems, today announced that it has entered into a definitive...
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
SAN DIEGO, CA / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" thanks to its...
S&W Seed Company to Delay Form 10-K Filing for Fiscal Year 2024
LONGMONT, Colo., Sept. 27, 2024 -- S&W Seed Company (Nasdaq: SANW) announced today that it plans to file a Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the fiscal year ended June 30, 2024. The delayed filing is due...
Greenfire to Oppose Challenge to Shareholder Rights Plan in Order to Protect All Shareholders
Calgary, Alberta--(September 27, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta, Canada...
InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Fireside Chat to be held at 3:30pm ET ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers...
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on healthy-aging research, today announced that Rob Fried, CEO of ChromaDex and Founder of Tru Niagen, will participate in a fireside chat...
Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference
CUPERTINO, Calif., Sept. 26, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
Encinitas, California--(September 25, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (KPRX) ("Kiora" or the "Company"), will participate in the following investor conferences. The presentations will be accessible live and on-demand for 90 days from our IR homepage...
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
Data Readout Expected Early Calendar 2025; NDA Submission on Track for 1H Calendar 2025PRINCETON, N.J., Sept. 25, 2024 -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of...